HC Wainwright & Co. Reiterates Buy on Vigil Neuroscience, Maintains $24 Price Target
Vigil Neuroscience, Inc. +8.94% Pre
Vigil Neuroscience, Inc. VIGL | 3.90 3.90 | +8.94% 0.00% Pre |
HC Wainwright & Co. analyst Andrew Fein reiterates Vigil Neuroscience (NASDAQ:
VIGL) with a Buy and maintains $24 price target.